Loading…
Epithelial cells that have undergone malignant transformation recruit various types of cells to construct their tumor microenvironment (TME). It includes cellular components like cancer cells, stromal cells, and immune cells. It also has non-cellular parts, such as blood vessels and signalling molecules. These elements interact with tumor cells. They change dynamically as the tumor progresses. They are markers of tumor progression. They also regulate tumor growth and metastasis. This happens through changes in the microenvironment.
In the tumors of patients with cancer, malignant cells are surrounded by a complex network of non-malignant cells that may have pro- or anti-tumorigenic effects depending on their cell type and abundance
The 3D architecture of tumors impacts the mechanical microenvironment of cancer, stromal cell accessibility, and invasion pathways.
Recent experiments have shown that the Tumor Microenvironment (TME) plays a crucial role in carcinogenesis and epithelial-mesenchymal transition.
The TME within the Bone marrow (BM) niche consists of elements that affect the progression, survival, proliferation, angiogenesis. The TME promotes an immunosuppressive environment in which immune recognition and response are suppressed.
This environment fosters the induction of tolerogenic DCs and regulatory T (Treg) cells, which suppress the development of protective effector T-cell responses.
An “infected” tumor microenvironment can provide a particularly fertile habitat for cancer and its stromal cells
The main cells of the Tumor Microenvironment (TME) in cancer immunity are NK cells, Dendritic Cells (DCs), CD8+ T cells, Treg cells, Fbroblasts, TAMs, and MDSCs
The tumor microenvironment (TME) is the area around a tumor that includes both cancer cells and other cells. These cells interact with each other, which helps the tumor grow. The TME has two main parts: nonimmune and immune components.
The TME can affect how well treatments work and whether the cancer becomes resistant to them. Because of this, targeting parts of the TME is a promising approach for developing new cancer treatments.
The tumor microenvironment (TME) has profound impacts on cancer progression and remodeling of the TME has emerged as a strategy to facilitate cancer therapy. Recently, great progress in TME modulation has been made, especially with the rapid developments in nanomedicine.
Tumor Microenvironment (TME) consists of Extracellular Matrix (ECM), stromal cells (such as Fbroblasts, mesenchymal stromal cells, Endothelial Cells / Endothelium, neurons, blood, and lymphatic network, etc.) and immune cells (including T cells / T lymphocytes and B cells / B Lymphocytes, natural killer cells , and tumor-associated macrophages , etc.)
Oncogenic change induces an inflammatory microenvironment. Inflammatory conditions are present before a malignant change.
see also:
Cancer microbiome / Tumor microbiota
Carcinogenesis / Oncogenesis / Tumorigenesis & Immunity